Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lability of antiretroviral drug resistance mutations--correlates with immunological and virological responses.

Current HIV research - 1 Jul 2007

Al Mazari Ali, Zomaya Albert Y, Charleston Michael, Salem Hanan, Maher AnnaMarie, Garsia Roger J

Abstract excerpt

This study assessed the relationship between changes in CD4 T-cell count, HIV Viral Load (VL) level and evolutionary patterns in Antiretroviral (ARV) resistance mutations of circulating HIV in those with persistent viraemia despite treatment. The study examined the dynamics of change in resistance mutations to explore potential predictors of evolution in the circulating virus over a prolonged period. Four...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Databases, Genetic

Share to Drug Resistance, Viral

Share to Forecasting

Share to Longitudinal Studies

Share to Viral Load

Source

Identifiers

PMID: 17627506
DOI: 10.2174/157016207781024009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lability of antiretroviral drug resistance mutations--correlates with immunological and virological responses.PMID 17627506Read ↗

Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.Semantic proximity Read ↗

Long-term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug-resistant genotypes.Semantic proximity Read ↗

Evolution of HIV resistance during treatment interruption in experienced patients and after restarting a new therapy.Semantic proximity Read ↗

Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing.Semantic proximity Read ↗

HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia.Semantic proximity Read ↗

Genetic evolution of HIV in patients remaining on a stable HAART regimen despite insufficient viral suppression.Semantic proximity Read ↗

Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring.Semantic proximity Read ↗

Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.Semantic proximity Read ↗

Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART.Semantic proximity Read ↗

Evolution of resistance during first-line treatment with boosted fosamprenavir is associated with baseline mutations.Semantic proximity Read ↗

Rapid, transient changes at the env locus of plasma human immunodeficiency virus type 1 populations during the emergence of protease inhibitor resistance.Semantic proximity Read ↗

Evolution of drug resistance after virological failure of a first-line highly active antiretroviral therapy regimen in Uganda.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.